Genuv’s Sungho Han Encourages Her Staff to Challenge the Status Quo
Genuv’s CEO Sungho Han, Ph.D., is a true Renaissance woman: a scientist, entrepreneur, patent law expert, conservatory-trained organist and visionary. Her approach to treating cancer and neurodegenerative diseases is powering Genuv to breakthroughs that promise new hope for patients with some of the most difficult-to-treat diseases. Dr. Han recently met with Gail Dutton, a writer for #Biospace, to discuss what drives her and her approach to drug development based on scientific imagination.
To view original article, please click here.